Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
Article
STIM1 long-term follow-up confirms imatinib discontinuation safety
Imatinib discontinuation is safe in patients with chronic myeloid leukemia who have sustained deep molecular response with no late molecular...
Article
Almost half of terminal cancer patient hospitalizations deemed avoidable
Nearly half of all intensive care unit hospitalizations among terminal oncology patients in a retrospective case review were identified as...
Article
Cost may hinder timely TKI initiation for CML
Nearly a third of Medicare beneficiaries with chronic myeloid leukemia did not initiate tyrosine kinase inhibitor therapy within 6 months of...
Article
FDA approves ustekinumab for adult Crohn’s disease
The Food and Drug Administration has approved ustekinumab (Stelara) for the treatment of moderately to severely active Crohn’s disease in adults...
Article
NIH workshop yields youth suicide prevention road map
The National Institutes of Health has released a 10-year road map for optimizing youth suicide prevention efforts.
News
FDA approves first automated insulin delivery system
The Food and Drug Administration has approved the first automated insulin delivery device for patients aged 14 years and older with type 1...
News
IVIg, corticosteroids appear comparable for ITP in pregnancy
Most pregnant women with a history of immune thrombocytopenia purpura need no treatment. For those who do, neonatal outcomes are comparable when...
News
ASPIRE trial: carfilzomib boosts quality of life in relapsed MM
Relapsed multiple myeloma patients treated with carfilzomib, lenalidomide, and dexamethasone (KRd) experienced improved Global Health Status/...
News
FDA approves ustekinumab (Stelara) for adult Crohn’s disease
The Food and Drug Administration has approved ustekinumab (Stelara) for the treatment of moderately to severely active Crohn’s disease in adults...
News
New-onset pediatric AD phenotype differs from adult AD
The skin phenotype of new-onset pediatric atopic dermatitis differs substantially from that in adult AD, which has important therapeutic...
News
No link between vasectomy, prostate cancer in U.S. cohort
Vasectomy does not appear to be associated with prostate cancer mortality or prostate cancer incidence, according to findings from a large U.S....
News
Biologic mesh for ventral hernia repair compared for recurrence, cost
The porcine acellular dermal mesh product Strattice was associated with significantly lower odds of hernia recurrence, compared with several other...
News
Aim for modulation with neurotoxin injections
BOSTON – When it comes to chemical denervation, it is best to aim for modulation rather than paralysis, according to Anthony Rossi, MD.
News
Minimal residual disease negativity predicts better survival in MM
Minimal residual disease negativity following treatment for newly diagnosed multiple myeloma is associated with long-term survival, according to...